Home     Archives     Search     Authors     About Us     Subscribe     Contact Us  


Search For:
Search In:
 




The i2P magazine is distributed by email on a monthly basis. Subscription is free and you can unsubscribe at any time.
Subscribe Here
Unsubscribe Here

If you have any concerns for your privacy, please read our Privacy Policy




- Issue 81: April 2009
- Issue 80: March 2009
- Issue 79: February 2009
- Issue 78: December 2008
- Issue 77: November 2008
- Issue 76: October 2008
- Issue 75: September 2008
- Issue 74: August 2008
- Issue 73: July 2008
- Issue 72: June 2008

More Archives
We are in the process of moving all of our articles to the new site.

In the meantime you can find them on the old i2P site.




Pharma-Goss

Rollo Manning
A Regular Column Reporting the News Behind the News

Issue 76: October 2008
Page: 1 of 1 Author's Profile | Send to a Friend | Printer Version

Pharma-goss   With Rollo Manning

 * CON GIVES THE EVIDENCE

 * MEDICINES AUSTRALIA COMES OUT ON TOP

 * NEWS ITEM POINTS TO POSSIBILITY OF CHANGE

______________________________________________________________________________

CON GIVES THE EVIDENCE
I2p correspondent and pharmacy researcher extraordinaire, Con Berbatis has hit the headlines again by showing the rate of adverse drug reaction s that are crippling not only the people who are the recipients of the therapy but also the public purse through hospitalization of the patients.
The National Medicines Policy seeks a co-operation between key stakeholders and this means maximum input from doctors and pharmacists in reporting adverse reactions as well as the warning for patients of side effects aText Box:  nd any adverse events that may cause concern.
The $5.99 dispensing fee is a reward for services provided and this will continue to be paid if it can be shown that the value is being added to the dispensing process.

MEDICINES AUSTRALIA COMES OUT ON TOP
All pharmacists will be aware of the marketing activities of the Big Pharma and other members of Medicines Australia whose 1500 products are listed on the Pharmaceutical Benefits Scheme. The amount of money spent on marketing is put at more than the amount spent on research and development. Since MA has adopted a code of conduct for its members it has been monitoring the activity of marketing to doctors and in particular the free lunches, dinners, boat cruises and the like that go towards making up the “marketing mix”.
A recent report stated the following:
An independent monitoring and audit process of 15,836 educational events sponsored or provided by pharmaceutical companies has found that all but 21 fully comply with the Medicines Australia Code of Conduct.
The 21 events identified by the Code Monitoring Committee as potentially breaching the Code have been referred to the independent Code of Conduct Committee for a final determination.
Medicines Australia chief executive Ian Chalmers said the half-yearly report of member companies’ educational events for healthcare professionals showed that companies were undertaking those events an ethical manner.

NEWS ITEM POINTS TO POSSIBILITY OF CHANGE

Text Box:



For anyone who thought competition policy had gone away they had better think again. Two recent news items point to the fact that the Rudd Labor Government has not finished with the deregulation agenda and as pointed out in this column earlier in the term of Labor the naming of the Department of Finance to the Department of Finance and Deregulation would not have been done just to give the printers more work.
The article by The Australian columnist David Uren and the full text of it can be read by
clicking here.

Comment to the Editor or email Rollo Manning on rollom@iinet.net.au

 


Back to Top | Back to Home
Copyright © Computachem Services, All Rights Reserved. Published by Computachem Services, PO Box 297 Alstonville 2477 NSW Australia